CT Cardiomegaly vs Tempus ECG-Low EF
AI Verdict
Choose CT Cardiomegaly if…
Choose CT Cardiomegaly if your facility regularly performs CT chest imaging and requires an automated, quantitative assessment of cardiothoracic ratio to aid in the detection and monitoring of cardiomegaly. This command-line software is ideal for integrating into existing radiology workflows to provide precise, objective measurements from CT scans, enhancing diagnostic reporting with both linear and area-based ratios. It's best suited for environments where detailed anatomical measurements from CT are paramount for cardiac evaluation.
View CT Cardiomegaly →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need a rapid, non-invasive screening tool to identify patients 40 years or older at risk of heart failure by detecting signs of low left ventricular ejection fraction (LVEF ≤40%) from standard 12-lead ECG recordings. This AI software is particularly useful in cardiology, emergency medicine, or internal medicine settings where quick risk stratification from readily available ECG data can prompt earlier and more targeted diagnostic follow-up for potential heart failure.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CT Cardiomegaly | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Fixed-fee | Unknown |
| Deployment | Docker Container (Ubuntu 20.04), command-line software | Integrates with current ECG platforms and electronic health records (EHRs). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF (Tool B) is designed for integration into existing healthcare facility workflows and medical systems, including EHRs, which streamlines its use for clinicians. In contrast, Innolitics' CT Cardiomegaly (Tool A) is described as command-line software deployed via Docker, suggesting a more technical and less intuitive user experience for the average clinical user.
Clinical Value
Tempus ECG-Low EFBoth tools are FDA-cleared and offer significant clinical value. However, Tempus ECG-Low EF (Tool B) identifies patients at risk for low left ventricular ejection fraction (LVEF), a critical indicator for heart failure, using a widely available and inexpensive ECG test. Its external validation and demonstrated clinical net benefit for identifying at-risk patients give it a slight edge in broader clinical impact.
Pricing & Value
Tempus ECG-Low EFNeither tool provides transparent pricing, requiring direct vendor contact. However, Tempus ECG-Low EF (Tool B) offers potentially higher value by leveraging an inexpensive and routinely performed diagnostic test (ECG) to identify patients at risk for a serious condition. This early identification can lead to timely interventions, potentially reducing the need for more costly downstream diagnostics and treatments.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF (Tool B) is explicitly designed for integration into healthcare facility workflows and medical systems, including electronic health records (EHRs), facilitating seamless adoption within large enterprises. Innolitics' CT Cardiomegaly (Tool A), as a command-line Docker container, may require more significant IT expertise and custom integration efforts for enterprise-wide deployment and maintenance.
Innovation
Tempus ECG-Low EFWhile both tools utilize AI, Tempus ECG-Low EF (Tool B) demonstrates a higher degree of innovation by extracting predictive insights for a critical cardiac condition (low LVEF) from a standard 12-lead ECG, a modality traditionally interpreted visually. The extensive training dataset of over 930,000 ECGs further highlights its advanced AI capabilities.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient comparative detail on the quality or extent of support and documentation for either tool. Both are FDA-cleared products from established companies, implying a baseline level of necessary documentation and support, making it difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CT Cardiomegaly | Tempus ECG-Low EF |
|---|---|---|
| Name | CT Cardiomegaly | Tempus ECG-Low EF |
| Company | Innolitics | Tempus AI |
| Primary Function | Automatically measures cardiothoracic ratio from CT chest images for cardiomegaly detection. | Analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%). |
| Input Data Type | CT chest images | 12-lead ECG recordings (resting, non-ambulatory) |
| Output | PDF and JSON reports, linear and area-based cardiothoracic ratios | Binary output (Low LVEF Detected / Not Detected) |
| Target Condition/Population | Cardiomegaly detection | Patients 40+ years at risk of heart failure (detects signs of low LVEF u226440%) |
| Key Technology/Methodology | AI-powered, machine learning algorithms for segmentation, non-adaptive machine learning using MONAI framework | AI-powered algorithm, trained on a large dataset of over 930,000 ECGs |
Videos
Demos, reviews, and walkthroughs featuring CT Cardiomegaly and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring CT Cardiomegaly or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.